Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/10/2860704/0/en/Altamira-Therapeutics-Provides-Business-Update-Reports-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/04/2857792/0/en/Altamira-Therapeutics-to-Host-Full-Year-2023-Financial-Results-and-Business-Update-Call-on-April-10-2024.html
https://www.globenewswire.com//news-release/2024/01/24/2815348/0/en/Altamira-Therapeutics-Files-Second-Provisional-Patent-Application-for-OligoPhore-Nanoparticles-Targeting-Different-KRAS-Mutations-in-Cancer-Treatment.html
https://www.globenewswire.com/news-release/2023/12/29/2802060/0/en/Altamira-Therapeutics-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html
https://www.globenewswire.com//news-release/2023/12/11/2793828/0/en/Altamira-Therapeutics-Provides-Investor-and-Business-Update.html
https://www.fiercebiotech.com/biotech/altamira-cuts-quarter-staff-amid-business-pivot
https://www.globenewswire.com/news-release/2023/12/05/2791274/0/en/Altamira-Therapeutics-to-Host-Investor-Business-Update-Call-on-December-11th.html
https://www.globenewswire.com//news-release/2023/11/29/2787904/0/en/Altamira-Therapeutics-Regains-Compliance-with-Nasdaq-Minimum-Stockholders-Equity-Requirement.html
https://www.globenewswire.com//news-release/2023/11/17/2782610/0/en/Altamira-Therapeutics-Announces-Partial-Spin-Off-of-Bentrio-Business.html
https://www.globenewswire.com//news-release/2023/11/10/2778332/0/en/Altamira-Therapeutics-Announces-European-Patent-Office-Decision-to-Grant-for-Patent-Application-Covering-Intranasal-Betahistine.html